Dela Cruz, Primitiva .

HRN: 27-46-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2025
METRONIDAZOLE 500MG (TAB)
07/16/2025
07/23/2025
PO
500 Mg
Q8h
Amoebiasis
Waiting Final Action 
07/16/2025
CEFUROXIME 750MG (VIAL)
07/16/2025
07/23/2025
IV
750mg
Q8
Infectious Diarrhe
Waiting Final Action 
07/17/2025
CIPROFLOXACIN 500MG (TAB)
07/17/2025
07/23/2025
PO
500 Mg
Bid
Amoebiasis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: